← All SRP filmsHealth headline satire / SRP original
The Health Trend Weather Report
A tornado of miracle claims hits the breakfast table. The forecast: confused toast, flying treadmills and a very questionable television advertisement.
1:53 RUN TIME1080p WEB EDITIONON-SCREEN CAPTIONSAI-ASSISTED PRODUCTION
Behind the story
Skeletide, GLP-14 and their advertisement are fictional satire. The film pokes fun at exaggerated health marketing, not real clinical evidence. Bring questions back to the claim, the evidence and what remains unknown.
Created for Simple Research Peptides. Original soundtrack, AI-assisted imagery and synthetic character narration. Source resolutions vary; this web edition is 1920 × 1080.
Explore beyond the screen
Separate a story from a claim. Use our Research Library to read evidence, limitations and open questions.
Browse the research guides ↗Read the dialogue transcript
A new miracle drug made landfall this morning.
Celebrities are asking everyone to buy it
and remain confused.
Carbs are the enemy!
Would you shut up?
You need carbs for energy!
At this point,
the toast is getting more exercise than you.
Lose 100% body fat in 90 days.
Ask your doctor about Skeletide.
Common side effects include nausea, fatigue,
and not showing up on an MRI scan.
Yesterday's new miracle has collided with today's new supplement.
We're expecting widespread uncertainty with almost
no visibility.
Correction.
The miracle is now available in watermelon.
What are you actually trying to understand?
Apparently,
breakfast!
Then let's start there.
You don't need a louder opinion.
You need information you can examine and
someone willing to explain it.
Good news,
sunshine and clear understanding.
Just in,
more misinformation heading our way.
Bring your questions to SRP.
Explore our research library or call or
text our team.
317-300-4596.
Download caption fileSRP original films use AI-assisted visuals and synthetic voices. Fictional stories and educational illustrations are not medical advice, treatment plans or promises of results.